Bausch Health
BHC
8.22
-0.34
-3.97%
Bausch Health
US · BHC
#2722 by market cap
Listed 1970
8.22
-0.34
-3.97%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:46
Recent news
-
Rating change
TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market Newswire · 2026/2/21
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8Market Newswire · 2026/1/7
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)TipRanks · 2026/4/27
-
Company notice
MCOM: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BHC HOLDINGS SDN. BHD.Bursa Malaysia · 2026/6/5
-
Rating change
Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market Newswire · 2025/8/5
-
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $9Market Newswire · 2026/11/11
-
Jefferies Initiates Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8Market Newswire · 2026/10/30
-
Rating change
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10Market Newswire · 2026/2/19
-
Rating change
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9Market Newswire · 2026/4/27
-
Rating change
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 2025/10/30
-
Rating change
BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5Market Newswire · 2026/2/19
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold RatingMarket Newswire · 2026/2/19
-
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market Newswire · 2026/10/29
-
Rating change
Truist Financial Initiates Bausch Health(BHC.US) With Hold RatingMarket Newswire · 2025/7/30
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8Market Newswire · 2026/1/24
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9Market Newswire · 2026/10/8
-
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $10Market Newswire · 2026/10/29
-
Rating change
A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $7 to $9Market Newswire · 2026/5/1
-
Rating change
TR | OpenAI - 4o Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $5.81Market Newswire · 2025/8/11
-
Rating change
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7Market Newswire · 2026/2/25
-
GUIDANCE: (BHC) Bausch Health Now Expects Fiscal 2026 Revenue Range $10.98B - $11.18B, Vs. FactSet Est of $10.96BMT Newswires · 2026/10/29
-
Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7Market Newswire · 2026/6/4
-
Rating change
Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $6.78Market Newswire · 2025/7/25
-
Earnings Call Summary | Bausch Health(BHC.US) Q1 2026 Earnings ConferenceMarket Newswire · 2026/4/30
-
Rating change
Analysts Offer Insights on Healthcare Companies: Heart Test Laboratories, Inc. (HSCS) and Bausch Health Companies (BHC)TipRanks · 2025/7/29
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:46:13 · For reference only, not investment advice and not tailored to your situation.
Bausch Health discussion 0 comments